Novanta Inc. (NASDAQ:NOVT – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on Tuesday after Robert W. Baird lowered their price target on the stock from $169.00 to $160.00. Robert W. Baird currently has a neutral rating on the stock. Novanta traded as low as $136.02 and last traded at $139.83, with a volume of 300155 shares trading hands. The stock had previously closed at $143.37.
Institutional Investors Weigh In On Novanta
Several large investors have recently added to or reduced their stakes in NOVT. Norges Bank bought a new stake in Novanta during the fourth quarter valued at $48,442,000. T. Rowe Price Investment Management Inc. boosted its stake in Novanta by 69.9% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 680,169 shares of the technology company’s stock valued at $103,910,000 after buying an additional 279,793 shares during the period. WCM Investment Management LLC bought a new stake in Novanta during the fourth quarter valued at $15,104,000. Schroder Investment Management Group boosted its stake in Novanta by 52.5% during the fourth quarter. Schroder Investment Management Group now owns 271,583 shares of the technology company’s stock valued at $41,359,000 after buying an additional 93,511 shares during the period. Finally, Millennium Management LLC lifted its stake in Novanta by 2,714.7% during the fourth quarter. Millennium Management LLC now owns 88,297 shares of the technology company’s stock worth $13,489,000 after purchasing an additional 85,160 shares during the last quarter. Institutional investors own 98.35% of the company’s stock.
Novanta Stock Performance
The company has a debt-to-equity ratio of 0.61, a current ratio of 2.79 and a quick ratio of 1.81. The company has a 50 day simple moving average of $148.13 and a 200-day simple moving average of $163.68. The stock has a market cap of $5.03 billion, a P/E ratio of 83.73 and a beta of 1.34.
About Novanta
Novanta, Inc engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products.
Read More
- Five stocks we like better than Novanta
- How to Use the MarketBeat Dividend Calculator
- GitLab: Get In While It’s Down—Big Rebound Ahead
- How to trade using analyst ratings
- Tesla Stock: Finding a Bottom May Take Time
- What Does Downgrade Mean in Investing?
- Duolingo: This Beaten-Down Stock Is About to Rally 38%
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.